These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


476 related items for PubMed ID: 17470604

  • 1. New advances in vaccine technology and improved cervical cancer prevention.
    Huh WK, Kendrick JE, Alvarez RD.
    Obstet Gynecol; 2007 May; 109(5):1187-92. PubMed ID: 17470604
    [Abstract] [Full Text] [Related]

  • 2. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

  • 3. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I.
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
    [Abstract] [Full Text] [Related]

  • 4. Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.
    Schwarz TF.
    Adv Ther; 2009 Nov; 26(11):983-98. PubMed ID: 20024678
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM, Bazaldua OV, Vargas L, Reile E.
    Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
    [Abstract] [Full Text] [Related]

  • 6. AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.
    Schwarz TF.
    Expert Rev Vaccines; 2008 Dec; 7(10):1465-73. PubMed ID: 19053203
    [Abstract] [Full Text] [Related]

  • 7. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A, Monk BJ.
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus vaccines for the treatment of cervical cancer.
    Sin JI.
    Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A, Schwarz TF, Hammerschmidt T, Siebert U.
    Med Klin (Munich); 2007 Jul 15; 102(7):515-23. PubMed ID: 17634869
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 20. [Anti-HPV vaccination: preventing cervical cancer].
    Simon P, Dupond I.
    Rev Med Brux; 2006 Sep 01; 27(4):S338-40. PubMed ID: 17091900
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.